Customization: | Available |
---|---|
Dossier: | Ctd,Actd |
GMP: | Chinese GMP |
Still deciding? Get samples of US$ 0.1/Piece
Request Sample
|
Suppliers with verified business licenses
Audited by an independent third-party inspection agency
Generic Name | Cefonicid Sodium for Injection |
Strength | 1g |
Packing | 10vials/box |
Origin | China |
It is suitable for infections caused by the following sensitive bacteria: lower respiratory tract infections, urinary tract infections, septicaemia, skin soft tissue infections, bone and joint infections. It can also be used in surgery to prevent infection. A single dose of 1g cefonicil given before surgery can reduce the incidence of postoperative infection due to contamination or potential contamination during surgery. The use of cefonicil during caesarean section (after cutting the umbilical cord) may reduce the incidence of some postoperative infections.
The dose and course of administration are determined according to the severity of infection, the patient's body condition and the sensitivity of bacteria. Cefonicil has a long half-life, and administration of 1g cefonicil can maintain 24 hours to achieve therapeutic effect on sensitive bacteria. The usual dose for adults is 1g every 24 hours and is available for intramuscular, intravenous and intravenous infusion. Up to 2g is also possible in some cases. The details are as follows:
Patients with normal renal function
The daily dose for mildly to moderately infected adults is 1g, once every 24 hours. In severe or life-threatening infections, 2g per day, once every 24 hours;
Uncomplicated urinary tract infection: 0.5g daily, once every 24 hours;
Surgical prevention of infection: A single dose of 1g is given 1 hour before surgery, and there is no need to use it again during and after surgery. If necessary, such as joint plastic surgery or thoracotomy can be repeated for 2 days; This product should be given only after umbilical ligation during pre-laparotomy.
The course of treatment depends on the condition.
Matters needing attention: